pSivida Corp (PSDV) - Product Pipeline Analysis, 2017 Update

Date: December 1, 2017
Pages: 37
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PD7BB10D01AEN
Leaflet:

Download PDF Leaflet

pSivida Corp (PSDV) - Product Pipeline Analysis, 2017 Update
Summary

pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. pSivida’s iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company offers drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. It operates in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company pSivida Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

NOTE: Out of security concerns GlobalData requires using corporate email address.
pSivida Corp Company Overview
pSivida Corp Company Snapshot
pSivida Corp Pipeline Products and Ongoing Clinical Trials Overview
pSivida Corp – Pipeline Analysis Overview
pSivida Corp - Key Facts
pSivida Corp - Major Products and Services
pSivida Corp Pipeline Products by Development Stage
pSivida Corp Ongoing Clinical Trials by Trial Status
pSivida Corp Pipeline Products Overview
Durasert - Back Of Eye Disease
Durasert - Back Of Eye Disease Product Overview
Durasert - Front Of Eye Disease
Durasert - Front Of Eye Disease Product Overview
Durasert - Knee Osteoarthritis
Durasert - Knee Osteoarthritis Product Overview
Durasert - Knee Osteoarthritis Clinical Trial
Durasert - Posterior Segment Uveitis
Durasert - Posterior Segment Uveitis Product Overview
Durasert - Posterior Segment Uveitis Clinical Trial
Durasert Latanoprost Implant
Durasert Latanoprost Implant Product Overview
DURASERT With TKI - Wet AMD
DURASERT With TKI - Wet AMD Product Overview
Next Gen Duraset - Posterior Segment Uveitis
Next Gen Duraset - Posterior Segment Uveitis Product Overview
Tethadur System
Tethadur System Product Overview
pSivida Corp - Key Competitors
pSivida Corp - Key Employees
pSivida Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
pSivida Corp, Recent Developments
Nov 07, 2017: pSivida Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution
Sep 11, 2017: pSivida Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results
Jul 18, 2017: Leading Retinal Specialists to Highlight pSivida's Durasert for Treatment of Posterior Segment Uveitis at Prestigious Ophthalmology Conferences
Jun 28, 2017: pSivida Enhances Board of Directors with Election of Veteran Healthcare Executive Kristine Peterson
Jun 22, 2017: pSivida Submits Marketing Authorization Application for Approval of Durasert Three-year Treatment for Posterior Segment Uveitis in the European Union
Jun 13, 2017: pSivida's Durasert Three-year Treatment for Posterior Segment Uveitis Successfully Achieves Primary Efficacy Endpoint in Second Phase 3 Study
May 08, 2017: Durasert Three-year Treatment for Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track
May 04, 2017: pSivida Provides Update On Durasert
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

pSivida Corp Pipeline Products and Ongoing Clinical Trials Overview
pSivida Corp Pipeline Products by Equipment Type
pSivida Corp Pipeline Products by Indication
pSivida Corp Ongoing Clinical Trials by Trial Status
pSivida Corp, Key Facts
pSivida Corp, Major Products and Services
pSivida Corp Number of Pipeline Products by Development Stage
pSivida Corp Pipeline Products Summary by Development Stage
pSivida Corp Ongoing Clinical Trials by Trial Status
pSivida Corp Ongoing Clinical Trials Summary
Durasert - Back Of Eye Disease - Product Status
Durasert - Back Of Eye Disease - Product Description
Durasert - Front Of Eye Disease - Product Status
Durasert - Front Of Eye Disease - Product Description
Durasert - Knee Osteoarthritis - Product Status
Durasert - Knee Osteoarthritis - Product Description
Durasert - Knee Osteoarthritis - A Pilot Study of a Dexamethasone Implant System in Humans
Durasert - Posterior Segment Uveitis - Product Status
Durasert - Posterior Segment Uveitis - Product Description
Durasert - Posterior Segment Uveitis - A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Durasert - Posterior Segment Uveitis - A Phase III, Multi-national, Multi-center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Durasert Latanoprost Implant - Product Status
Durasert Latanoprost Implant - Product Description
DURASERT With TKI - Wet AMD - Product Status
DURASERT With TKI - Wet AMD - Product Description
Next Gen Duraset - Posterior Segment Uveitis - Product Status
Next Gen Duraset - Posterior Segment Uveitis - Product Description
Tethadur System - Product Status
Tethadur System - Product Description
pSivida Corp, Key Employees
pSivida Corp, Subsidiaries
Glossary

LIST OF FIGURES

pSivida Corp Pipeline Products by Equipment Type
pSivida Corp Pipeline Products by Development Stage
pSivida Corp Ongoing Clinical Trials by Trial Status

COMPANIES MENTIONED

Radius Health Inc
Eli Lilly and Co
Akers Biosciences Inc
Skip to top


Ask Your Question

pSivida Corp (PSDV) - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: